Takeda has yet to file for approval of its vaccine candidate to treat dengue, but it now has a €130 million plant and 200 jobs relying on that nod. The Japanese company today said it has opened the plant Singen, Germany, which will handle formulation, fill, finish and secondary packaging of the dengue vaccine candidate, starting with the packaging line. Source: Fierce Pharma 6/11/2019